Replies to post #184978 on Biotech Values

[stockbettor]

ENTA should be up huge, now at $51.50

The initial price on opening is well below pre-market. But IMO that should change when it sinks in that ENTA is a royalty company as to Viekira (and, for that matter, as to the second generation compound containing ABT-493 assuming it makes it to market).

Hope Dew is working on a revised ENTA valuation.